Cargando…
Avapritinib in advanced gastrointestinal stromal tumor: case series and review of the literature from a tertiary care center in India
The therapeutic landscape in advanced gastrointestinal stromal tumor has evolved. Avapritinib and ripretinib have now been approved by the US FDA for platelet-derived growth factor alpha D842V-mutant and refractory gastrointestinal stromal tumor patients, respectively. Here we report five patients w...
Autores principales: | Verma, Saurav, Reddy, Rohit, Chandrashekhara, Sheragaru Hanumanthappa, Shamim, Shamim Ahmed, Tripathy, Sarthak, Rastogi, Sameer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015663/ https://www.ncbi.nlm.nih.gov/pubmed/33815822 http://dx.doi.org/10.2144/fsoa-2020-0178 |
Ejemplares similares
-
Indian experience with immunotherapy in sarcoma and gastrointestinal stromal tumors: a retrospective study
por: Reddy, Rohit, et al.
Publicado: (2022) -
Insights into the medical management of gastrointestinal stromal tumours: lessons learnt from a dedicated gastrointestinal stromal tumour clinic in North India
por: Baa, Annie Kanchan, et al.
Publicado: (2023) -
Management and outcomes of advanced hemangioendothelioma at a medical oncology clinic in an Indian tertiary care center
por: Tansir, Ghazal, et al.
Publicado: (2023) -
Imaging in Sternal Tumours: A Pictorial Review
por: Singh, Anuradha, et al.
Publicado: (2017) -
Role of CT in the detection and management of cancer related complications: a study of 599 patients
por: Bansal, Abhinav, et al.
Publicado: (2023)